Re: Caution urged in interpreting a negative study of cannabis use and schizophrenia: a response to Dr. Christine Miller.
Re: Caution urged in interpreting a negative study of cannabis use and schizophrenia: a response to Dr. Christine Miller.
复制标题
回复:在解释大麻使用和精神分裂症的负面研究时应谨慎:对克里斯汀·米勒博士的回应。
DOI:
10.1016/j.schres.2014.02.012
复制
发表时间:
2014
影响因子:
4.5
通讯作者:
Delisi,LynnE
中科院分区:
文献类型:
--
作者:
Delisi,LynnE
On behalf of my co-authors, I thank Dr. Miller for her thoughtful comments about our study (Proal et al., 2014). However, her title is quite misleading in that it implies that our study was “negative” and that we were simply reporting that cannabis does not “cause” schizophrenia. This is not so; unfortunately one sentence in the conclusion was taken out of context and as such was misleading. Our study was a family study of people who did and did not abuse cannabis as adolescents. There were 4 groups: non-psychotic individuals who did and did not abuse cannabis and people with schizophrenia who did and did not abuse cannabis prior to their illness. What the main study analysis showed was that those individuals who developed schizophrenia after cannabis use in adolescents had a significantly greater family history of schizophrenia than those who used cannabis and did not develop schizophrenia and an elevated family history no different than those with schizophrenia who never used cannabis. These results suggest that the key element for determining whether someone develops schizophrenia after cannabis use is an elevated genetic risk.We did not test in this study design whether cannabis use without a family history of psychosis could cause schizophrenia. In order to test that hypothesis one would need to perform a longitudinal study examining people with and without cannabis abuse who have no family history of schizophrenia and determine whether over time there would be a significant excess of schizophrenia in those that used cannabis compared with those who did not. The converse of this longitudinal design, which we proposed as the next step to our study, would be to examine people at high genetic risk for schizophrenia and compare those who did and did not abuse cannabis for significant differences in later development of schizophrenia. The latter would show an interaction of genes with environment to cause illness. The former might show that cannabis alone could “cause” schizophrenia. We believe the issue is not so much that the sample size was underpowered to detect differences related
登录
查看更多内容
影响因子:
2.8
作者:
D. Männel
通讯作者:
D. Männel
DOI:
--
发表时间:
1982
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Marino,PA;Adams,DO
通讯作者:
Adams,DO
影响因子:
4.4
作者:
L. Ruco;Monte S. Meltzer
通讯作者:
Monte S. Meltzer
影响因子:
64.8
作者:
J. Ortaldo;L. Mason;B. Mathieson;S. Liang;D. A. Flick;R. Herberman
通讯作者:
R. Herberman
影响因子:
3.9
作者:
Pal, Nabanita;Kim, Taeyeon;Park, Jae-Seo;Cho, Eun-Bum
通讯作者:
Cho, Eun-Bum